The test analyzes the levels of two proteins in the blood and has shown a link between these levels and patient outcomes. The pilot study showed that 98% of patients with low protein levels did not develop secondary breast cancer. The test could be ready for approval in two to three years.
Latest News
14:35
Canada wants to participate in the EU’s €90 billion loan for Ukraine in an effort to strengthen its relationship with Europe
14:26
Poland’s Foreign Minister claims that NATO could quickly defeat Russia if Moscow attacked the alliance
14:26
The European Commission approves aid of 52 million euros for Romanian cattle breeders affected by rising fuel prices
14:21
The AEP allocated 15.47 million lei to the parties in September. The PSD received the largest amount
14:17
Finland joins the nuclear deterrence initiative proposed by France
See more news